ReviewCancers2022

Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations.

Stanislas Quesada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.